Predictive role of SLC1A5 in neuroblastoma prognosis and immunotherapy
Abstract Background Neuroblastoma, a prevalent extracranial solid tumor in pediatric patients, demonstrates significant clinical heterogeneity, ranging from spontaneous regression to aggressive metastatic disease. Despite advances in treatment, high-risk neuroblastoma remains associated with poor su...
Saved in:
Main Authors: | Jian Cheng, Miaomiao Sun, Xiao Dong, Yang Yang, Xiaohan Qin, Xing Zhou, Yongcheng Fu, Yuanyuan Wang, Jingyue Wang, Da Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2025-01-01
|
Series: | BMC Cancer |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12885-025-13560-y |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
SLC1A5 is a key regulator of glutamine metabolism and a prognostic marker for aggressive luminal breast cancer
by: Lutfi H. Alfarsi, et al.
Published: (2025-01-01) -
Single-cell profiling of SLC family transporters: uncovering the role of SLC7A1 in osteosarcoma
by: Yan Liao, et al.
Published: (2025-01-01) -
Ketamine Infusion as an Adjunct to Opioid Analgesia in Pediatric Patients with High-Risk Neuroblastoma Undergoing Treatment with Dinutuximab: Adverse Effects and Safety in a Non-ICU Setting
by: Streby KA, et al.
Published: (2025-01-01) -
Isocitrate Dehydrogenase 1 and 2 Mutations in Pediatric Neuroblastoma Patients
by: Emre LEVENTOGLU, et al.
Published: (2023-06-01) -
Deep learning for stage prediction in neuroblastoma using gene expression data
by: Aron Park, et al.
Published: (2019-09-01)